Top View
- Beneficial Effect of Combination Therapy with Mitiglinide And
- Advanced Therapeutic Options for Management of the Type II Diabetic Patient in Primary Care
- A Prospective, Randomized, Multicenter Trial Comparing The
- Diabetes Mellitus (1 of 42)
- Construction of Effective and Safe Glycemic Control in the Elderly by Using Continuous Glucose Monitoring
- Product Monograph Starlix (Nateglinide)
- Implications of Postprandial Hyperglycaemia and Role
- Anatomical Classification Guidelines V2018 EPHMRA ANATOMICAL
- Recommendations of the SEC (Endocrinology & Metabolism)
- Drugs in Pipeline for Type-2 Diabetes R Mahajan, K Gupta
- Pharmaceutical Composition for Preventing Or Treating Diabetes, Containing Zinc Salt, Cyclo-Hispro and Antidiabetic Drug As Active Ingredients
- Adult Type 2 Diabetes Insulin Guidelines INTRODUCTION
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2018
- Product Monograph Including Patient Medication Information
- Novel Therapeutic Advancements in Type 2 Diabetes
- ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
- Effects of Voglibose and Nateglinide on Glycemic Status and Coronary
- Favorable Cardiovascular Effects of Pioglitazone: a Meta-Analysis
- Safety and Efficacy of Fixed Dose Combination of Voglibose, Glimepiride and Metformin in Indian Type 2 Diabetes Mellitus Patients
- SEC (Endocrinology & Metabolism) Made in Its 87Th Meeting Held On
- Analytical Method Development and Validation for Simultaneous Estimation of Voglibose and Mitiglinide Calcium Hydrate in Pharmaceutical Dosage Form
- Study the Effect of Metformin, Voglibose Alone and in Combination
- Metadoze V PI
- The Avandia Debate
- Avandamet, INN-Rosiglitazone/Metformin
- Comparison of Metabolic Profile and Adiponectin Level with Pioglitazone Versus Voglibose in Patients with Type-2 Diabetes Mellitus Associated with Metabolic Syndrome
- JMSCR Vol||06||Issue||07||Page 806-816||July 2018
- Anatomical Classification Guidelines V2006A EPHMRA ANATOMICAL
- Ryzodeg, INN-Insulin Degludec/Insulin Aspart
- FORXIGA® Data Sheet 091120 Copyright 2
- Pharmacotherapeutics of Miglitol: an Α-Glucosidase Inhibitor
- Medications for Hyperglycemia in Type 2 Diabetes and Review of Insulin Degludec and Dapagliflozin
- Efficacy of Adding Once- and Thrice-Daily Voglibose in Japanese Type 2 Diabetic Patients Treated with Alogliptin
- Abridged Prescribing Information Cetapin® V Metformin
- Development of Nateglinide Oral Controlled Release Formulation to Achieve Ideal Control of Blood Glucose Level for Type 2 Diabetes
- Comparison of Acarbose and Voglibose in Diabetes Patients Who
- Enhancement of Postprandial Endogenous Insulin Secretion
- Efficacy and Safety of Thiazolidinediones In
- Overview of Type 2 Diabetes Drugs on the Market
- Pharmacologically Relevant Drug Interactions of Α-Glucosidase Inhibitors
- Development and Validation of Rapid RP-HPLC and Green Second
- Screening of Novel Drugs Against Alpha-Glucosidase, a Key Enzyme in Diabetes
- Analysis of Voglibose Using an Agilent LC with Mass Selective Detection
- Improvement in Blood Glucose Fluctuations in Type 2 Diabetes
- Wo 2010/045656 A2
- Online-Only Supplemental Material
- The Role of Prandial Pramlintide in the Treatment of Adolescents with Type 1 Diabetes
- Voglibose: an Alpha Glucosidase Inhibitor Endocrinology Section
- Glimepiride 1Mg/2Mg Metformin SR 500Mg Voglibose 0.2Mg
- Prospective Multicenter Observational Study of Voglibose in Type 2 Diabetes—VICTORY
- Research Journal of Pharmaceutical, Biological and Chemical Sciences
- Identification and Characterization of Antidiabetic And
- Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
- Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus
- 1. Generic Name Glimepiride +Metformin + Voglibose 2
- Treatment of Insulin Resistance S Kalra, B Kalra, P Batra
- Recommendations for Management of Diabetes During Ramadan Update 2010
- WO 2017/198177 Al 23 November 2017 (23.11.2017) W !P O PCT
- Avandia, Supported on the Basis of Preclinical Studies and Clinical Efficacy and Safety